Equities

HighTide Therapeutics Inc

HighTide Therapeutics Inc

Actions
  • Price (HKD)0.89
  • Today's Change0.04 / 4.71%
  • Shares traded823.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments736840765
Total Receivables, Net162.343.64
Total Inventory------
Prepaid expenses265.733.85
Other current assets, total0.682.752.40
Total current assets779851775
Property, plant & equipment, net154.813.45
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets1.3000
Total assets795856779
LIABILITIES
Accounts payable31226.09
Accrued expenses109.485.49
Notes payable/short-term debt3.501,2687.00
Current portion long-term debt/capital leases2.471.110.25
Other current liabilities, total33199.70
Total current liabilities801,32029
Total long term debt101.511,007
Total debt161,2711,014
Deferred income tax------
Minority interest------
Other liabilities, total1.995.1216
Total liabilities921,3261,051
SHAREHOLDERS EQUITY
Common stock0.360.040.03
Additional paid-in capital2,316283283
Retained earnings (accumulated deficit)(1570)(724)(559)
Treasury stock - common(0.04)(0.01)0.00
Unrealized gain (loss)------
Other equity, total(43)(30)3.73
Total equity703(471)(272)
Total liabilities & shareholders' equity795856779
Total common shares outstanding473473473
Treasury shares - common primary issue424242
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.